Seoul National University Hospital at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Seoul National University Hospital brings 7 presentations from 1 research group to ASHG 2026 in Montréal. Its ASHG 2026 program centres on cancer genetics, with emphasis on glioma and treatment-related brain toxicity. The Lee Lab presents mosaic driver mutations linked to poor glioblastoma prognosis.
| Organization | ASHG 2026 Attendance |
|---|---|
Seoul National University Hospital Seoul, South Korea | 1 PI |
Lee Labjooholeelab.com Investigates glioma and brain-radiation toxicity using genome-wide screening, organoids, brain-on-chip, mouse models and patient tissues/images. Studies neural-stem-cell tumor origins and radiotherapy resistance.
| Poster Fri Oct 23 2:30 pm Prevalent mosaic driver mutations in the subventricular zone associated with poor prognosis of glioblastoma CancerMosaicismStem cellOncogenesis |
| 6 more presenters — research group not yet identified | |
Instantly find 20 buyers from Seoul National University Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction